
Kelvin Health 2022 Recap
The year 2022 proved to be very dynamic and rewarding for Kelvin Health. We focused deeply on the CVD indications; achieved significant progress in further
The year 2022 proved to be very dynamic and rewarding for Kelvin Health. We focused deeply on the CVD indications; achieved significant progress in further
Our CEO Georgi Kadrev was invited to present Kelvin Health’s mission and vision of precise and accessible rapid diagnostics of socially significant diseases, in the the company of 14 other heavily funded startups.
Happy to share Kelvin Health was awarded Health Tech Innovation of the Year 2022 in Med-Tech World’ 22 – one of the most inspiring large-scale
So excited to share that our Medical Director, prof. Ivo Petrov, received the greatest recognition for his work – the award Doctor of the Year
We are honored to announce that Kelvin Health just won Roche’s HealthCareLab challenge in the Screening and Early Diagnostics track! We are delighted we successfully
Cardiovascular disease (CVD) is the leading cause of death worldwide, taking about 17.9 million lives in 2019. Statistics have risen after the Covid 19 pandemic
2021 was extremely dynamic and rewarding year for Kelvin Health. The company has made important advancement in developing our AI-based platform for non-invasive screening, monitoring and
We are excited to announce that Kelvin Health won the BIOME Summit Cardiovascular Innovation Challenge Montreal ’21! The prestigious jury selected Kelvin Health as the
Happy to announce that we are joining forces with Prof. Ivo Petrov and Dr. Zoran Stankov from Acibadem City Clinic in our goal to build
University Medical Center Maribor, Slovenia and First Gynaecological Hospital St. Sofia, Bulgaria are the first two hospitals that will partner in the data collection process